About | Free Trial

Last Update

2016-04-27T00:00:00.000Z

This profile was last updated on . .

Is this you? Claim your profile.

Wrong Daniel Khesin?

Mr. Daniel Khesin

Chief Executive Officer

DS Laboratories Inc

Direct Phone: (516) ***-****       

Email: d***@***.com

DS Laboratories Inc

1601 Green Road

Pompano Beach, Florida 33064

United States

Company Description

DS Laboratories is committed to being a consummate corporate citizen. We strongly believe that as a business we have a responsibility to society, the environment, and to improving the lives of those around us. We strongly believe that some of the most ... more

Find other employees at this company (53)

Background Information

Education



Hunter College

Web References (182 Total References)


DS Healthcare Group Inc (NASDAQ:DSKX) Shareholder Alert: Lawsuit Alleges False and Misleading Statements | Apr 27, 2016 - SBWire

www.sbwire.com [cached]

Additionally, DS Healthcare Group Inc disclosed that the Audit Committee and independent counsel had started an investigation into the Company President, Daniel Khesin's, involvement in the allegedly fraudulent revenue recognition and equity transaction errors; and that Mr. Khesin's employment as President of DS Healthcare Group Inc has been terminated for cause based on the current results of the investigation.


Robbins Arroyo LLP: DS Healthcare Group, Inc. (DSKX) Misled Shareholders According to a Recently Filed Class Action | Business Wire

feeds.businesswire.com [cached]

DS also disclosed that its Board of Directors terminated Daniel Khesin as President for cause and removed him as its Chairman of the Board for cause because they believed he violated his fiduciary duty to the company and its subsidiaries and may have violated federal law. Then, on April 3, 2016, DS disclosed that Khesin engaged in inappropriate conduct, additional violations of the federal securities laws, and intimidation and defamation against Board members, management, and outside professionals. On this news, DS stock fell $0.18 per share, or over 21%, to close at $0.67 per share before NASDAQ halted trading on April 4, 2016. On April 5, 2016, DS filed a verified emergency motion for temporary restraining order and preliminary injunction to protect the company from Khesin's alleged continued unlawful misconduct.


Daniel Khesin ...

www.sec.gov [cached]

Daniel Khesin


DS Healthcare also revealed ...

bespc.com [cached]

DS Healthcare also revealed that the Audit Committee and independent counsel had started an investigation into the involvement of the company's President, Daniel Khesin, in the allegedly fraudulent revenue recognition and equity transaction errors; and that Mr. Khesin's employment as President of DS Healthcare has been terminated for cause based on the current results of the investigation.


Barch-Niles succeeds Daniel ...

www.addthisproduct.com [cached]

Barch-Niles succeeds Daniel Khesin, DS Healthcare's founding CEO.

...
Khesin will continue to serve as Chairman and will lead product innovation.

Similar Profiles

Other People with this Name

Other people with the name Khesin

Michael Khesin
Intempus Realty

Lev Khesin
Sky Technics Group

Max Khesin
Natural Synergies Inc

Alex Khesin
Google Inc

Sophia Khesin
Comverse Technology , Inc.

Browse ZoomInfo's Business Contact Directory by City

Browse ZoomInfo's
Business People Directory

Browse ZoomInfo's
Advanced Company Directory